NBC News · Cost of Denial
Cost of Denial — inside America's health-insurance denials
NBC News' ongoing investigation into health-insurance claim denials — Erin McLaughlin's reports for the series have followed patients fighting for doctor-recommended care and documented insurers' responses.
Cost of Denial is a continuing NBC News investigation into how health insurers decide what care to cover — and what happens to patients when they say no.
Erin McLaughlin’s reports for the series have followed patients appealing denials of doctor-recommended treatment, including a cancer patient fighting for coverage and military families insured through TriWest. In cases covered by her reporting, insurers reversed denials after NBC News began asking questions. In one segment, a health-care chief executive apologized to patients for coverage failures.
Why it mattered
The series has documented concrete results: insurers reversing denials after NBC News inquiries and a health-care CEO apologizing to patients on the record.
Related reporting
-
Cancer patient's fight for doctor recommended treatment
NBC Nightly News segment from the Cost of Denial investigation following a cancer patient's battle against an insurer's denial of doctor-recommended treatment.
Watch report at NBC News → -
Military families call out healthcare company
Cost of Denial segment on military families insured through TriWest who say the health-care company failed to deliver the coverage they were owed.
Watch report at NBC News → -
Healthcare CEO apologizes for coverage problems
NBC Nightly News report in which a health-care chief executive apologizes to patients for coverage failures documented by the Cost of Denial investigation.
Watch report at NBC News → -
Family fights for coverage of autism therapy
Cost of Denial segment following a family fighting their insurer for coverage of their child's autism therapy.
Watch report at NBC News → -
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
Investigation into counterfeit weight-loss drugs reaching American patients, including the case of a Tennessee woman accused of selling fake medication.
Read story at NBC News →